Pharmafile Logo
Pharmafocus logo
Advanced Search

Jardiance scores more cardiovascular outcomes data

November 10, 2015
Manufacturing and Production Boehringer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Victoza, cardiovascular outcomes, diabetes, empagliflozin, jardiance, lilly, liraglutide, type 2 diabetes

A sub-group analysis of data from an outcomes study of Boehringer Ingelheim’s and Lilly’s Jardiance has found the diabetes drug …

News

Health minister criticised for blocking Off-Patent Drugs Bill debate

November 9, 2015
Research and Development, Sales and Marketing Alistair Burt, Breast Cancer Now, MS Society, Off-Patent Drugs Bill

A Parliamentary Bill backing the wider use of off-patent drugs has been kicked into the long grass after the Government …

News
EMA HQ

EMA concludes HPV vaccines do not cause CRPS or POTS

November 9, 2015
Sales and Marketing EMA, HPV, HPV vaccine, PRAC, complex regional pain syndrome, drug safety, postural orthostatic tachycardia syndrome

The European Medicines Agency says there is no evidence from a detailed scientific review of reports linking complex regional pain …

News
UNITAID

Medicines Patent Pool to include hep C and TB drugs

November 9, 2015
Sales and Marketing Medicines Patent Pool, affordable drugs, hep C, hepatitis, hepatitis C, medicines access, tuberculosis

The Medicines Patent Pool has expanded to include a mandate to make treatments for hepatitis C and tuberculosis affordable and …

News
clinical trials

Governments and industry ‘combining to stall drug development’

November 9, 2015
Research and Development, Sales and Marketing BMJ, R&D, drug development

Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …

News
Pfizer logo

Pfizer to double patient assistance allowance in the US

November 9, 2015
Sales and Marketing Drug pricing, Pfizer

Pfizer says it will double the allowable income level for its RxPathways patient assistance program in the US with immediate …

News
gsk_hq

GSK asthma drug Nucala gets FDA approval

November 6, 2015
GSK, Nucala, asthma, eosinophils, mepolizumab

GlaxoSmithKline has received approval from the FDA for Nucala as an add-on maintenance treatment of patients with severe asthma aged …

News
boehringers_current_board

Boehringer announces board changes, chairman’s retirement

November 6, 2015
Medical Communications, Sales and Marketing

Boehringer Ingelheim has announced that Professor Andreas Barner will retire as chairman of the Board of Managing Directors on 30 …

Appointment

UK doctors embracing technology, but not for their patients, survey reveals

November 6, 2015
Medical Communications, Research and Development

A global online survey of doctors released by market research agency Cello Health Insight has indicated that although UK doctors …

News
dollar-544956_1280

Top 5 pharma companies’ Q3 results

November 6, 2015
Medical Communications, Sales and Marketing financial results, revenue, sales

The leading pharma players have been able to report largely positive financial results to their shareholders in the third quarter …

Feature
astrazeneca image

AstraZeneca acquires ZS Pharma for $2.7bn, announces Q3 results

November 6, 2015
Medical Communications AstraZeneca, M&A, MA, ZS Pharma, ZS-9, acquisitions, financial results, hyperkalaemia, mergers

AstraZeneca has announced its acquisition of ZS Pharma for an all-cash total of $2.7 billion. In the latest mega-money deal …

News
Sanofi logo

Sanofi buys in new diabetes drug

November 6, 2015
Medical Communications, Research and Development, Sales and Marketing Lexicon Pharma, SGLT2, SGLT2 inhibitors, Sanofi, sotagliflozin

Sanofi has paid an initial $300 million for collaboration and license agreement to develop sotagliflozin, one of a newer class …

News
Olivier Brandicourt

Brandicourt sets out Sanofi’s long-term vision

November 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, olivier brandicourt, pharma strategy

Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …

News
nsclc_merck_pfizer

Merck and Pfizer begin new Phase III avelumab trial in lung cancer

November 5, 2015
Medical Communications, Research and Development Merck, Pfizer, avelumab, lung cancer, non-small cell lung cancer

Merck and Pfizer have commenced an international Phase III study of the investigational cancer immunotherapy avelumab in patients with non-small …

News
Ikervis

New treatments to boost dry eye drug market – if approved

November 5, 2015
Sales and Marketing Allergan, Ikervis, Restasis, Shire, cyclosporine, dry eye disease, dry eye syndrome, lifitegrast

The global market for treatments for dry eye syndrome will double in value to an estimated $4.6 billion by 2024, …

News
eye

Featured market report: Summary of dry eye syndrome

November 5, 2015
dry eye disease, dry eye syndrome, lifitegrast

This report provides the current prevalent population for dry eye syndrome across seven major markets.It includes data for the USA, …

Feature
Pascale Witz Sanofi

Sanofi and Hanmi partner to create long-acting diabetes treatments

November 5, 2015
Manufacturing and Production, Research and Development Korea, Sanofi, diabetes, hanmi

Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …

News
OECD logo

OECD report warns of high spend and slow growth for pharma industry

November 5, 2015
Manufacturing and Production, Sales and Marketing OECD, pharmaceutical spending

The high prices that pharma companies charge for specialty medicines are straining the health budgets of wealthy nations, according to …

News
President Obama

Obama government launches drug price crackdown

November 4, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, President Obama, US, affordability, market access

President Obama has launched an ‘Affordable Drug Pricing Task Force’, aimed at tackling the spiralling cost of certain prescription medications …

News

NHS England reinstates treatments to Cancer Drugs Fund

November 4, 2015
Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NHS England

Five treatments in seven indications have been reinstated to Cancer Drugs Fund, as a result of negotiations between pharma companies …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026